Nearly 160 medical specialists who frequently use magnetic resonance imaging equipment will know by mid-July how they performed on the debut version of a credentialing test evaluating knowledge of MRI safety.
Geographic disparities in access to organs remain a major issue in the U.S. Some in the transplant community say a proposal to fix the problem focuses too much on “shuffling organs” and too little on boosting low donor rates.
Hill-Rom, a Chicago-based medical equipment manufacturer, announced it will acquire Welch Allyn, a Skaneateles Falls, N.Y.-based manufacturer of diagnostic and patient-monitoring equipment.
Fitbit plans to raise up to $358 million in its initial public offering, according to a U.S. Securities and Exchange Commission filing made Tuesday. Since 2007, Fitbit has sold roughly 20.5 million of its fitness-tracking devices, with 10.9 million devices sold last year alone.
A Republican-run House committee voted Tuesday to repeal a 2.3% tax on many medical devices that helps pay for President Barack Obama's healthcare overhaul.
Dr. Francis “Jay” Crosson named chairman of the Medicare Payment Advisory Commission, and other news makers
Dr. Francis “Jay” Crosson has been named chairman of the Medicare Payment Advisory Commission, which advises Congress on Medicare spending.
Fans of cheesy 1970s TV shows will remember “The Six Million Dollar Man,” the story of Steve Austin, a critically injured astronaut who is rebuilt with bionic parts. Austin, played by Lee Majors, goes on to become a special agent who uses his superhuman abilities to help the government.
A jury has ordered Boston Scientific to pay $100 million to a woman who, despite two surgeries, still has pieces of transvaginal mesh embedded inside her.
Federal investigators are reportedly conducting a probe of medical devices linked to the spread of uterine cancer, and examining what Johnson & Johnson, at one time the largest manufacturer of laparoscopic power morcellators, knew about their dangers before pulling them from the market in 2014.
The first report from a big public-private project to improve genetic testing reveals it is not as rock solid as many people believe, with flaws that result in some people wrongly advised to worry about a disease risk and others wrongly told they can relax.
Why is the nation's capital suddenly obsessed with biomedical innovation? And why is the fruit of that obsession, the 21st Century Cures Act, moving like a greased pig through the usually deadlocked Congress—even as some experts warn it could undermine the FDA's ability to protect the public...
Learn how innovative hospitals leverage processes, people and technology to better manage this complex patient population and avoid potential CMS readmission penalties.